Patent details

EP1846018 Title: TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS

Basic Information

Publication number:
EP1846018
PCT Application Number:
PCT/US/2005/047483
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058559683
PCT Publication Number:
WO/2006/083455
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
French Title of Invention:
ADMINISTRATION CIBLEE DE TOXINE BOTULINIQUE POUR LE TRAITEMENT ET LA PREVENTION DE CEPHALEES TRIGEMINO-AUTONOMIQUES, DE MIGRAINES ET DE PATHOLOGIES VASCULAIRES
German Title of Invention:
GEZIELTE ABGABE VON BOTULINUMTOXIN ZUR BEHANDLUNG UND PRÄVENTION VON TRIGEMINALEN AUTONOMEN CEPHALGIEN, MIGRÄNE UND GEFÄSSERKRANKUNGEN
SPC Number:

Dates

Filing date:
29/12/2005
Grant date:
09/07/2014
EP Publication Date:
09/07/2014
PCT Publication Date:
10/08/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/10/2007
EP B1 Publication Date:
09/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/12/2014
Expiration date:
29/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/12/2005
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

Name:
Blumenfeld Andrew M.
Address:
United States (US)

Priority

Priority Number:
593641 P
Priority Date:
01/02/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages